FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Authority Hl7

31,787 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 5800 - 6000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1233.jsonPartial Arthroplasty of Hipactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1234.jsonPartial Arthroplasty of Hipactive2023-07uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1235.jsonRemoval, Revision and Supplement Procedures of the Lower Body and Spineactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1236.jsonRemoval, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1237.jsonRemoval, Revision and Supplement Procedures of the Lower Body and Spineactive2023-07uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1238.jsonPrimary THA Procedureactive2023-07uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1239.jsonFoot Ulceractive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1240.jsonFoot Ulceractive2023-07usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1241.jsonFoot Ulceractive2023-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1242.jsonReferral for Foot Careactive2023-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1243.jsonTherapeutic Footwearactive2023-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1244.jsonFoot Deformityactive2023-07ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1245.jsonFoot Deformityactive2023-07usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1246.jsonFoot Deformityactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1247.jsonMegestrol Medicationsactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1248.jsonMeperidine Medicationsactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1249.jsonPotentially Harmful Antidepressants for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.11.1004.jsonFluoride Varnish Application for Childrenactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.11.1007.jsonDental Cariesactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.11.1009.jsonDental Cariesactive2017-05usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.11.1010.jsonClinical Oral Evaluationactive2017-05us
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.11.1011.jsonFluoride Varnish Application for Childrenactive2024-02us
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.12.1002.jsonFluoride Varnish Application for Childrenactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.12.1003.jsonClinical Oral Evaluationactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.125.12.1004.jsonDental Cariesactive2021-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1250.jsonPotentially Harmful Antihistamines for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1251.jsonPotentially Harmful Antiparkinsonian Agents for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1252.jsonPotentially Harmful Barbiturates for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1253.jsonPotentially Harmful Estrogens for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1254.jsonPotentially Harmful Gastrointestinal Antispasmodics for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1255.jsonPotentially Harmful Pain Medications for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1256.jsonPotentially Harmful Skeletal Muscle Relaxants for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1257.jsonPotentially Harmful Sulfonylureas for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1258.jsonSubstance Use Disorder Long Acting Medicationactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1259.jsonSubstance Use Disorder Short Acting Medicationactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1260.jsonViloxazineactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1266.jsonDiabetic Retinopathy Severity Levelactive2025-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1272.jsonDiabetesactive2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1273.jsonDiabetesactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.195.11.1003.jsonCounseling for Nutritionactive2017-05uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.195.11.1004.jsonCounseling for Nutritionactive2023-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.195.12.1003.jsonCounseling for Nutritionactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1001.jsonAntibiotic Medications for Pharyngitisactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1078.jsonNifedipine Medicationsactive2022-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1080.jsonContraceptive Medicationsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1109.jsonMeperidine Medicationsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1129.jsonDesiccated Thyroid Medicationsactive2021-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1143.jsonIsotretinoinactive2022-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1167.jsonDipyridamole Medicationsactive2021-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1205.jsonLeucovorinactive2023-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1211.jsonAspirin and Other Antiplateletsactive2024-06usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1212.jsonDTaP Vaccineactive2024-11uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1214.jsonHepatitis A Vaccineactive2018-03uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1216.jsonHepatitis B Vaccineactive2025-04uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1220.jsonChild Influenza Vaccineactive2022-02uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1222.jsonInactivated Polio Vaccine (IPV)active2021-09uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1228.jsonPneumococcal Conjugate Vaccineactive2023-11uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1232.jsonRotavirus Vaccine (3 dose schedule)active2018-03uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1234.jsonVaricella Zoster Vaccine (VZV)active2017-05uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1235.jsonMeasles, Mumps and Rubella (MMR) Vaccineactive2017-05uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1252.jsonGuanfacine Medicationsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1255.jsonMegestrol Medicationsactive2021-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1256.jsonMeprobamate Medicationsactive2021-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1266.jsonAromatase Inhibitorsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1267.jsonGlucocorticoids (oral only)active2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1481.jsonPotentially Harmful Nonbenzodiazepine Hypnotics for Older Adultsactive2024-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1482.jsonPotentially Harmful Antiinfectives for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1517.jsonDementia Medicationsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1530.jsonAntidepressant Medicationactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.11.1532.jsonPotentially Harmful Antipsychotics for Older Adultsactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1001.jsonAntibiotic Medications for Pharyngitisactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1080.jsonContraceptive Medicationsactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1143.jsonIsotretinoinactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1170.jsonVaricella Zoster Vaccine (VZV)active2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1205.jsonLeucovorinactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1211.jsonAspirin and Other Antiplateletsactive2024-06usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1213.jsonAntidepressant Medicationactive2021-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1214.jsonDTaP Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1215.jsonHepatitis A Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1216.jsonHepatitis B Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1218.jsonChild Influenza Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1219.jsonInactivated Polio Vaccine (IPV)active2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1221.jsonPneumococcal Conjugate Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1223.jsonRotavirus Vaccine (3 dose schedule)active2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1224.jsonMeasles, Mumps and Rubella (MMR) Vaccineactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1265.jsonAromatase Inhibitorsactive2018-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1266.jsonGlucocorticoids (oral only)active2018-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1480.jsonPotentially Harmful Nonbenzodiazepine Hypnotics for Older Adultsactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1481.jsonPotentially Harmful Antiinfectives for Older Adultsactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1510.jsonDementia Medicationsactive2019-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1522.jsonPotentially Harmful Benzodiazepines for Older Adultsactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.196.12.1523.jsonPotentially Harmful Antipsychotics for Older Adultsactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1005.jsonBilateral Mastectomyactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1009.jsonPrimary THA Procedureactive2023-07uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1015.jsonFlexible Sigmoidoscopyactive2023-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1016.jsonFlexible Sigmoidoscopyactive2017-12uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1017.jsonFlexible Sigmoidoscopyactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1020.jsonFecal Occult Blood Test (FOBT)active2017-12usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1023.jsonGroup A Streptococcus Testactive2024-11usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1024.jsonHbA1c Laboratory Testactive2023-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1026.jsonHysterectomy with No Residual Cervixactive2023-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1027.jsonHysterectomy with No Residual Cervixactive2024-11ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1035.jsonTotal Colectomyactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1036.jsonTotal Colectomyactive2021-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1055.jsonXRay Studyactive2022-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1061.jsonGastric Bypass Surgeryactive2020-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1062.jsonGastric Bypass Surgeryactive2018-03uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1080.jsonPrimary THA Procedureactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1084.jsonHistory of bilateral mastectomyactive2017-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1085.jsonHistory of bilateral mastectomyactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1086.jsonStatus Post Left Mastectomyactive2018-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1087.jsonStatus Post Right Mastectomyactive2018-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1089.jsonUnilateral Mastectomy, Unspecified Lateralityactive2017-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1090.jsonUnilateral Mastectomy, Unspecified Lateralityactive2017-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1091.jsonStatus Post Left Mastectomyactive2017-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1092.jsonStatus Post Right Mastectomyactive2017-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1096.jsonMajor Transplantactive2021-09uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1097.jsonMajor Transplantactive2021-08uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1132.jsonUnilateral Mastectomy Leftactive2021-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1133.jsonUnilateral Mastectomy Rightactive2021-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1134.jsonHysterectomy with No Residual Cervixactive2023-09usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1135.jsonHysterectomy with No Residual Cervixactive2020-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1140.jsonBilateral Mastectomyactive2019-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1143.jsonTotal Colectomyactive2019-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1144.jsonUnilateral Mastectomy Leftactive2019-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1145.jsonUnilateral Mastectomy Rightactive2019-03uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.11.1148.jsonPalliative Interventionactive2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1005.jsonBilateral Mastectomyactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1006.jsonPrimary THA Procedureactive2023-08usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1010.jsonFlexible Sigmoidoscopyactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1011.jsonFecal Occult Blood Test (FOBT)active2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1012.jsonGroup A Streptococcus Testactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1013.jsonHbA1c Laboratory Testactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1014.jsonHysterectomy with No Residual Cervixactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1019.jsonTotal Colectomyactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1034.jsonXRay Studyactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1050.jsonGastric Bypass Surgeryactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1068.jsonHistory of bilateral mastectomyactive2017-12usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1069.jsonStatus Post Left Mastectomyactive2017-12usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1070.jsonStatus Post Right Mastectomyactive2017-12usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1071.jsonUnilateral Mastectomy, Unspecified Lateralityactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1075.jsonMajor Transplantactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1133.jsonUnilateral Mastectomy Leftactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1134.jsonUnilateral Mastectomy Rightactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.198.12.1135.jsonPalliative Care Interventionactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1064.jsonAnaphylactic Reaction to DTaP Vaccineactive2022-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1100.jsonMalabsorption Syndromesactive2023-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1102.jsonMalabsorption Syndromesactive2022-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1105.jsonIntussusceptionactive2017-05usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1106.jsonIntussusceptionactive2021-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1107.jsonInfluenza Virus LAIV Vaccineactive2021-02uscvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.11.1108.jsonInfluenza Virus LAIV Vaccine Administeredactive2021-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1031.jsonAnaphylactic Reaction to DTaP Vaccineactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1050.jsonMalabsorption Syndromesactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.199.12.1056.jsonIntussusceptionactive2017-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2446.jsonLower Extremity Visual Inspection Testactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2447.jsonPedal Pulse Result or Findingactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2448.jsonMonofilament Test Result or Findingactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2449.jsonMonofilament Testsactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2450.jsonLower Extremity Neurological Assessment Result or Findingactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2451.jsonLower Extremity Neurological Testsactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2452.jsonLower Extremity Visual Inspection Result or Findingactive2023-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1004.2616.jsonAutonomous Eye Exam Result or Findingactive2025-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.1577.jsonPharmacologic Therapy for Hypertensionactive2021-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1036.jsonChronic Kidney Disease, Stage 5active2017-05usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1037.jsonChronic Kidney Disease, Stage 5active2017-05ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1049.jsonPatient Provider Interactionactive2020-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1058.jsonPsych Visit for Family Psychotherapyactive2017-05uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1063.jsonOccupational Therapy Evaluationactive2017-08uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1067.jsonDementia and Mental Degenerationsactive2024-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1068.jsonDementia and Mental Degenerationsactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1069.jsonStandardized Tools for Assessment of Cognitionactive2017-05usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1071.jsonRadiation Treatment Managementactive2017-08uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1072.jsonRadiation Treatment Managementactive2017-05ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1073.jsonStandardized Pain Assessment Toolactive2017-05usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1078.jsonCanceractive2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1079.jsonCanceractive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1080.jsonChemotherapy Administrationactive2024-01uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1081.jsonChemotherapy Administrationactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.111.jsonOphthalmological Servicesactive2021-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.113.jsonProstate Cancer Treatmentactive2025-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.118.jsonInitial Myocardial Infarctionactive2020-03usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.119.jsonInitial Myocardial Infarctionactive2024-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.120.jsonCoronary Artery Disease No MIactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1238.jsonEjection Fractionactive2025-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1243.jsonPsychoanalysisactive2017-05uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1244.jsonRenal Failure Due to ACE Inhibitoractive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1251.jsonGroup Psychotherapyactive2017-05uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1256.jsonAllergy to ACE Inhibitor or ARBactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1257.jsonIntolerance to ACE Inhibitor or ARBactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.133.jsonBeta Blocker Therapyactive2023-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1333.jsonAllergy to Beta Blocker Therapyactive2019-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1334.jsonIntolerance to Beta Blocker Therapyactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1341.jsonHeart Rateactive2024-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1342.jsonBeta Blocker Therapy for LVSDactive2022-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1344.jsonAcute and Subacute Iridocyclitisactive2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1353.jsonLimited Life Expectancyactive2025-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1363.jsonAnnual Wellness Visitactive2023-12uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1364.jsonMacular Examactive2021-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1372.jsonTobacco Use Screeningactive2017-05usloinc